The largest database of trusted experimental protocols

13 protocols using phtpp

1

Cell Proliferation Assays with Estrogen Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
In preparation for cell proliferation assays, cells were cultured at a final cell number of 50,000 cells/ ml in phenol red-free RPMI media (Sigma-Aldrich, Poole, UK) to eliminate the weak oestrogenic effect of this indicator. This media was supplemented with 10% stripped FCS to remove any steroids in the serum. Cells were cultured in the absence or presence of 17β-estradiol (E2), an ERα and ERβ agonist; the highly selective ERα antagonist 1,3-Bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H–pyrazole dihydrochloride (MPP), or ERβ antagonist 4-[2-Phenyl-5,7-bis (trifluoromethyl) pyrazolo[1,5-a]pyrimidin-3-yl]phenol (PHTPP) (Tocris Bioscience, Bristol, UK). The 5′-bromo-2′-deoxyuridine (BrdU) cell proliferation assay kit (Roche-Applied-Science, Burgess Hill, UK) was used to measure replication of genomic DNA as an indirect parameter of the cell proliferation rate. The Caspase-Glo 3/7 apoptosis assay (Promega, Southampton, UK) and the lactate dehydrogenase activity (LDH) assay (Sigma-Aldrich, Poole, UK) were used to determine the cell proliferation rates in the presence of the MPP or PHTPP.
+ Open protocol
+ Expand
2

Prostate Cancer Cell Line Experiments

Check if the same lab product or an alternative is used in the 5 most similar protocols
PNT1a cells were obtained from M. Littmann (Baylor College of Medicine, Houston). The human prostate cancer cell line, LNCaP was obtained from American Type Culture Collection (ATCC). PC3-M cells were obtained from R. C. Bergan (Northwestern University, Chicago). 3β-androstane-diol (3β-Adiol) and PHTPP experiments were performed by incubating cells with 3β-Adiol (5 μM; Sigma) or PHTPP (10 μM; Tocris) for 2–3 days. The generation of ERβ-ablated PNT1a cells, PHD2-ablated PNT1a cells and HIF-1α ablated cells has been described previously [9 (link)]. IKKβ ablated PC3-M cells were generated using shRNAs (Open Biosystems; TRCN0000018918 and TRCN0000018919). Stable cell transfectants were generated by puromycin or hygromycin selection (0.5 μg/mL for PNT1a and 2 μg/mL for PC3-M cells). The resultant ERβ, HIF-1α-ablated cells were used for subsequent experiments. For experiments involving hypoxia, cells were incubated with 100 μM cobalt chloride for 22–24 hours.
+ Open protocol
+ Expand
3

Estrogen Receptor Modulation in Endometrial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Endometrial stromal cells and granulosa cells were treated with propyl-pyrazole-triol (PPT), a ERα-selective agonist [38 (link),39 (link),40 (link)];
diarylpropionitrile (DPN), a ERβ-potency selective agonist [41 (link),42 (link),43 (link)]; methyl-piperidino-pyrazole (MPP), a selective ERα
antagonist [42 (link), 44 (link), 45 (link)]; or 4-[2-phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-α]pyrimidin-3-yl]phenol (PHTPP), a selective ERβ
antagonist [46 (link)].
E2 (Sigma-Aldrich) and PHTPP (Tocris Bio, Ellisville, MO, USA) were initially dissolved in sterile ethanol. PPT
(Sigma-Aldrich), MPP (Sigma-Aldrich) and DPN (Tocris Bioscience) were initially dissolved in dimethyl sulfoxide (DMSO).
Before use, the compounds were diluted in serum-free culture medium. The final concentrations of ethanol or DMSO were <
0.01%.
+ Open protocol
+ Expand
4

Multimodal Approach to Neuropathic Pain

Check if the same lab product or an alternative is used in the 5 most similar protocols
Faslodex (20 mg/kg; Abcam ab120131), a clinically used general estrogen receptor inhibitor, and ERβ specific inhibitor PHTPP (1.7mg/kg; Sigma Aldrich SML1355) were diluted in corn oil and administered systemically. Drug or vehicle (corn oil) was administered via intraperitoneal injection first at CCI. Treatment with Xpro1595 (10 mg/kg; intraperitoneal; INmuneBio), a dominant negative sTNF inhibitor, or vehicle (0.1M PBS) began 7 days post-CCI. Previously mentioned drugs were given every 48 hours until experiment termination. SB203580, a p38αβ MAPK inhibitor (Invivogen tlrl-sb20), was diluted to 4.54mg/mL in PBS and delivered to the CNS at 0.11μL/hr via osmotic pump (Azlet 1004) administering the drug at 0.5μg/hr with intrathecal cannula (Azlet Brain Infusion Kit3). Pumps containing SB203580 or vehicle were inserted during CCI via cannulation at the T12 vertebrae level.
+ Open protocol
+ Expand
5

Androstenedione and H2O2-Induced Cell Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
The unattached cells were eliminated and the cells were treated in a new cell culture media consisting of F12 medium supplemented with 2% FBS and 0.1 µM androstenedione. ACT-A (R&D systems, Minneapolis, MN, USA) was dissolved in the new media at 50 ng/mL. The H2O2 was diluted to 0.4 mM, as previously reported [22 (link),23 (link)]. PHTPP (4-[2-Phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-a]-pyrimidin-3-yl] phenol, Sigma, Burlington, MA, USA) was used at the concentration of 10 µM, as previously described [24 (link),25 (link)]. The cells were treated for 24 h and harvested for mRNA and protein detection.
+ Open protocol
+ Expand
6

Investigating Ovarian Toxicity Mechanisms

Check if the same lab product or an alternative is used in the 5 most similar protocols
4-vinylcycohexene diepoxide (VCD; 160 mg/kg; Sigma-Aldrich) diluted in corn oil (vehicle) was administered by i.p. injection for 20 consecutive d. Minocycline hydrochloride (50 mg/kg; Sigma-Aldrich) dissolved in sterile PBS was administered by i.p. injection for 5 d/week (2 wk), and controls received PBS injections. The selective ERβ antagonist PHTPP (4 mg/kg body weight; Sigma-Aldrich) was dissolved in corn oil and administered i.p. for 5 d/week (6 wk to 3 mo of age). Controls received i.p. corn oil injections.
+ Open protocol
+ Expand
7

Chondrocyte Differentiation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dulbecco's modified Eagle's medium and Ham's F-12 medium (DMEM/F12; Hyclone), fetal bovine serum (FBS; Gibco), penicillin-streptomycin (Invitrogen), 17β-Estradiol (Sigma-Aldrich), ERα antagonist methyl-piperidino-pyrazole (MPP; Sigma-Aldrich), ERβ antagonist 4-[2-phenyl-5,7-bis (tri-fluoro-methyl) pyrazolo [1,5-a] pyrimidin-3-yl] phenol (PHTPP; Sigma-Aldrich), dimethyl sulfoxide (DMSO; Invitrogen), Rabbit polyclonal antibody to Col II (Abcam) and Col X (Abcam), Rabbit polyclonal antibody to GAPDH (Abcam). Estradiol, MPP, and PHTPP were dissolved in DMSO according to manufacture protocol.
+ Open protocol
+ Expand
8

Endometrial Carcinoma Cell Culture and Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human endometrial carcinoma Ishikawa and HEC-1A cells were purchased from the Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences (Shanghai, China), and cultured in RPMI-1640 and DMEM/F12 medium supplemented with 10% FBS (Gibco, Auckland, NZ) at 37ºC in a humidified atmosphere with 5% CO2, respectively. In addition, Ishikawa cells were treated in triplicate with vehicle (control) or ICI182870 (0.1–2.5 µM) or PHTPP (0.5 or 5 µM, Sigma-Aldrich, USA) for 24 h.
+ Open protocol
+ Expand
9

Antagonistic Effects on Cellular Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
MPP (methyl-piperidino-pyrazole, an alpha-antagonist), THC (tetrahydrocannabinol, a beta-antagonist), and PHTPP (4-[2-phenyl-5,7-bis(trifluoromethyl) pyrazolo[1,5-a]pyrimidin-3-yl]phenol, a beta-antagonist) were purchased from Sigma and added to the cultures at a concentration of 10 nM (based on the pilot dose–response results).
+ Open protocol
+ Expand
10

Autophagy Regulation in Apoptosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
All reagents were commercially obtained and of analytical grade. E2, PHTPP, YVAD-cmk, 3-methyladenine (3-MA), and rapamycin were obtained from Sigma-Aldrich (St. Louis, MO, USA). Antibodies used for Western blot were as follows: caspase 3, caspase 8, caspase 9, LC3-b, beclin 1, P62, phosphor-mTOR (Ser2448), phosphor-S6K1 (Thr389), phosphor-AMPKα (Thr172), and β-actin. Antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). All antibodies were used in a dilution of 1:1,000.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!